4/6/22 16:05 | 4/4/22 | OCDX | Health | Diagn | In Vitro & In Vivo Diagnostic | Schlesinger Michael A. | NJ | O | EVP,GC,S | M.d | 553 | 6.28 | 0 | 88 | | 88 | D | | | | | | | | | | | | | | |
4/6/22 16:05 | 4/4/22 | OCDX | Health | Diagn | In Vitro & In Vivo Diagnostic | Schlesinger Michael A. | NJ | O | EVP,GC,S | S.d | -1,652 | 18.77 | 0 | -88 | -50 | 88 | D | | | | | | | | | | | | | | |
1/5/22 16:23 | 1/3/22 | OCDX | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Christopher M | NJ | DO | CB,CEO | M.d | 1,256 | 12.56 | 0 | 100 | 37 | 367 | D | | | | | | | | | | | | | | |
1/5/22 16:23 | 1/3/22 | OCDX | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Christopher M | NJ | DO | CB,CEO | S.d | -2,110 | 21.10 | 0 | -100 | -21 | 367 | D | | | | | | | | | | | | | | |
1/5/22 16:23 | 1/3/22 | OCDX | Health | Diagn | In Vitro & In Vivo Diagnostic | Schlesinger Michael A. | NJ | O | EVP,GC,S | M.d | 816 | 6.28 | 0 | 130 | | 88 | D | | | | | | | | | | | | | | |
1/5/22 16:23 | 1/3/22 | OCDX | Health | Diagn | In Vitro & In Vivo Diagnostic | Schlesinger Michael A. | NJ | O | EVP,GC,S | S.d | -2,742 | 21.09 | 0 | -130 | -60 | 88 | D | | | | | | | | | | | | | | |
10/19/21 16:15 | 10/15/21 | OCDX | Health | Diagn | In Vitro & In Vivo Diagnostic | Schlesinger Michael A. | NJ | O | EVP,GC,S | M.d | 474 | 6.28 | 0 | 75 | 620 | 88 | D | | | | | | | | | | | | | | |
10/19/21 16:15 | 10/15/21 | OCDX | Health | Diagn | In Vitro & In Vivo Diagnostic | Schlesinger Michael A. | NJ | O | EVP,GC,S | S.d | -1,489 | 19.73 | 0 | -75 | -46 | 88 | D | | | | | | | | | | | | | | |
9/16/21 16:30 | 9/14/21 | OCDX | Financ | InvAdv | Investment Advice | Carlyle Group Inc. | DC | T | | S | -425,040 | 16.80 | 0 | -25,300 | -18 | 118,106 | I | | | | | | | | | | | | | | |
8/18/21 17:41 | 8/16/21 | OCDX | Health | Diagn | In Vitro & In Vivo Diagnostic | Schlesinger Michael A. | NJ | O | EVP,GC,S | M.dm | 283 | 6.28 | 0 | 45 | 106 | 88 | D | | | | | | | | | | | | | | |
8/18/21 17:41 | 8/16/21 | OCDX | Health | Diagn | In Vitro & In Vivo Diagnostic | Schlesinger Michael A. | NJ | O | EVP,GC,S | S.dm | -906 | 20.13 | 0 | -45 | -34 | 88 | D | | | | | | | | | | | | | | |
8/13/21 17:22 | 8/11/21 | OCDX | Health | Diagn | In Vitro & In Vivo Diagnostic | Schlesinger Michael A. | NJ | O | EVP,GC,S | M.dm | 534 | 6.28 | 0 | 85 | 999% | 88 | D | | | | | | | | | | | | | | |
8/13/21 17:22 | 8/11/21 | OCDX | Health | Diagn | In Vitro & In Vivo Diagnostic | Schlesinger Michael A. | NJ | O | EVP,GC,S | S.dm | -1,683 | 19.80 | 0 | -85 | -49 | 88 | D | | | | | | | | | | | | | | |
8/4/21 18:29 | 8/2/21 | OCDX | Health | Diagn | In Vitro & In Vivo Diagnostic | Yates Robert Clifton | NJ | D | | M.d | 145 | 6.28 | 0 | 23 | | 5 | D | | | | | | | | | | | | | | |
8/4/21 18:29 | 8/2/21 | OCDX | Health | Diagn | In Vitro & In Vivo Diagnostic | Yates Robert Clifton | NJ | D | | S.dm | -7,418 | 21.71 | 0 | -342 | -99 | 5 | D | | | | | | | | | | | | | | |
8/4/21 18:29 | 8/2/21 | OCDX | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Christopher M | NJ | DO | CB,CEO | S.m | -5,890 | 21.82 | 0 | -270 | -42 | 367 | D | | | | | | | | | | | | | | |